Drug

MAVRILIMUMAB

Drug TypeAction TypeMechanism of ActionApprovedMax Trial PhaseMax GBM Phase
Antibody ANTAGONIST Granulocyte-macrophage colony-stimulating factor receptor antagonist no 2 0